You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Novel Methods to Monitor Health Status and Clinical Laboratory Data: Portable Acquisition, Assessment, and Reporting

    SBC: Mimosa Acoustics Inc.            Topic: OSD09H26

    Mimosa Acoustics will develop a portable binaural audiological device, based on our successful HearID system. HearID is a clinical system for otoacoustic emission and middle-ear power analysis testing; it is FDA and CE-marked. The new system will have the ability to conduct a variety of audiological tests especially for use in hearing-conservation programs, including: flexible otoacoustic emission ...

    SBIR Phase II 2011 Department of DefenseDefense Health Agency
  2. Synthetic Tissue Trainer- Development of Realistic Tissue Elements for Surgical Task Training for Mangement of Combat Injuries

    SBC: SIM-VIVO LLC            Topic: OSD10H09

    The main outcome of this proposal will be the development of a new generation of task training manikins that will provide a realistic training platform for the instruction of invasive trauma resuscitation procedures (ITRP) such as peripheral IV insertion,

    SBIR Phase I 2011 Department of DefenseDefense Health Agency
  3. Noninvasive Measurements of Intracranial Pressure

    SBC: ALPERIN NONINVASIVE DIAGNOSTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Elevated intracranial pressure (ICP) remains a critical problem in management of patients with neurological problems and is the most common cause of death in these patients. Elevated ICP can be managed and treated if detected at an early stage. Therefore, measurement of ICP is important for diagnosis and treatment decisions. At this time only invasive technique ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  4. An FPGA-based Real-Time Volume Rendering System

    SBC: BIO-IMAGING RESEARCH, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project involves the research and development of a real-time FPGA-based volume rendering system. In many scientific, engineering and medical diagnostic imaging applica

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  5. FIBER-OPTIC-LINKED PRESSURE SENSOR (FOLPS)

    SBC: BIOTECHPLEX CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): There is a critical need and very large market for a miniature ultra-low pressure transducer to monitor pressure within confined body spaces for both animal and human application. Thus, BioTechPlex proposes to de

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. A CELL LINE FOR ANTIASTHMA DRUG DISCOVERY

    SBC: BIOTECHPLEX CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): BioTechPlex Corporation (BioTechPlex) proposes to develop a stable, genetically engineered human bronchial epithelial cell line that can produce a measurable signal when an "asthma specific" regulatory protein in a

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Ultra-High Dose-Rate Aerosol Drug Delivery

    SBC: BIOTECHPLEX CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Of the 30 million US patients who suffer from respiratory disorders, over 4 million require frequent inhaled medication. Therapy sessions can last from several minutes to 3 hours. In addition, inhaled drugs are incr

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Therapeutic Workplace Treatment: Widespread Deployment

    SBC: BUSINESSTECH CONSULTING, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The Therapeutic Workplace is an efficacious, computerized treatment designed to address the chronic, persistent nature of drug addiction and unemployment by integrating abstinence reinforcement contingencies of pro

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  9. Microwave Technology for Superfund Site Remediation

    SBC: CHA CORP.            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term objective of the proposed work is to build a commercial-scale portable microwave system that is capable of regenerating 50-kg/hrof saturated carbon. This process will also be capable of recovering solv

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Ex vivo assessment for cardiovascular toxicity of drugs

    SBC: CORDYNAMICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Unanticipated reports of lethal arrhythmias associated with clinically approved drugs, such as terfenadine (Seldane(R)) and cisapride (Propulsid(R)), have led the Food and Drug Administration to recommend that all n

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government